1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CSOM230C2402, EUDRACT 2009-016722-13, 2009-016722-13, NCT01137682
|
|
2.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: EudraCT 2006-004748-22, NCT01203306
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CALGB-80701, CALGB-80701, NCT01229943
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: BJT-NEC-001, NCT01480986
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GETNE 1003, CRAD001KES08T, NCT01567488
|
|
6.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: MDA-2009-0734, 2009-0734, 8354, NCT01204476
|